Jason B. Lindsey

发表

Repeat Revascularization After Contemporary Percutaneous Coronary Intervention: An Evaluation of Staged, Target Lesion, and Other Unplanned Revascularization Procedures During the First Year

Michael J Pencina, Laura Mauri, David J Cohen, 2012, Circulation. Cardiovascular interventions.

Cardiovascular safety of liraglutide assessed in a patient-level pooled analysis of phase 2—3 liraglutide clinical development studies

J. Buse, K. Kennedy, J. House, 2011, Diabetes & vascular disease research.

Association Between Circulating Soluble Receptor for Advanced Glycation End Products and Atherosclerosis

A. Khera, C. Ayers, Anand Rohatgi, 2009, Diabetes Care.

Association Between Circulating Soluble Receptor for Advanced Glycation End Products ( sRAGE ) and Atherosclerosis : Observations from the Dallas Heart Study

A. Khera, C. Ayers, Anand Rohatgi, 2009 .

ST-Segment elevation acute myocardial infarction due to severe hypotension and proximal left subclavian artery stenosis in a prior coronary artery bypass graft patient.

Subhash Banerjee, E. Brilakis, Jason B. Lindsey, 2009, Cardiovascular revascularization medicine : including molecular interventions.

Comparison of bleeding complications using arterial closure device versus manual compression by propensity matching in patients undergoing percutaneous coronary intervention.

K. Kennedy, D. Safley, S. Marso, 2011, The American journal of cardiology.

Drug-Eluting Stents and the Use of Percutaneous Coronary Intervention Among Patients With Class I Indications for Coronary Artery Bypass Surgery Undergoing Index Revascularization

J. Spertus, D. Cohen, S. Marso, 2022 .

Steatosis and diastolic dysfunction: the skinny on myocardial fat.

S. Marso, Jason B. Lindsey, 2008, Journal of the American College of Cardiology.

Transparency of appropriateness criteria.

S. Marso, J. Stolker, Jason B. Lindsey, 2010, Journal of the American College of Cardiology.

Bleeding in Patients Undergoing Percutaneous Coronary Intervention: The Development of a Clinical Risk Algorithm From the National Cardiovascular Data Registry

Sunil V. Rao, J. Spertus, E. Peterson, 2009, Circulation. Cardiovascular interventions.

Clinical update: atrial septal defect in adults

L. Hillis, Jason B. Lindsey, L. Hillis, 2007, The Lancet.

The association of differing measures of overweight and obesity with prevalent atherosclerosis: the Dallas Heart Study.

A. Khera, S. Grundy, J. D. de Lemos, 2007, Journal of the American College of Cardiology.

The impact of bivalirudin on percutaneous coronary intervention-related bleeding.

E. Mahoney, D. Cohen, K. Kennedy, 2010 .

Acute coronary syndrome due to extrinsic compression of the left main coronary artery in a patient with severe pulmonary hypertension: successful treatment with percutaneous coronary intervention.

E. Brilakis, Jason B. Lindsey, S. Banerjee, 2008, Cardiovascular revascularization medicine : including molecular interventions.

Receptor for advanced glycation end-products (RAGE) and soluble RAGE (sRAGE): cardiovascular implications

Darren K Mcguire, F. Cipollone, Shuaib M. Abdullah, 2009, Diabetes & vascular disease research.

Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry.

M. Pencina, S. Goldberg, N. Kleiman, 2009, JACC. Cardiovascular interventions.

Prognostic Implications of Creatine Kinase-MB Elevation After Percutaneous Coronary Intervention: Results From the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) Registry

M. Pencina, N. Kleiman, D. Cohen, 2011, Circulation. Cardiovascular interventions.

Predicting Restenosis of Drug-Eluting Stents Placed in Real-World Clinical Practice: Derivation and Validation of a Risk Model From the EVENT Registry

M. Pencina, L. Mauri, N. Kleiman, 2010, Circulation. Cardiovascular interventions.

Registry Development of a Clinical Risk Algorithm From the National Cardiovascular Data Bleeding in Patients Undergoing Percutaneous Coronary Intervention :

J. Spertus, E. Peterson, M. Roe, 2009 .

Diabetes Duration Is Associated With Increased Thin-Cap Fibroatheroma Detected by Intravascular Ultrasound With Virtual Histology

K. Kennedy, J. House, S. Marso, 2009, Circulation. Cardiovascular interventions.

Mode of death after contemporary percutaneous coronary intervention: a report from the Evaluation of Drug Eluting Stents and Ischemic Events registry.

N. Kleiman, D. Cohen, K. Kennedy, 2011, American heart journal.

Independent associations between metabolic syndrome, diabetes mellitus and atherosclerosis: observations from the Dallas Heart Study

A. Khera, C. Ayers, S. Grundy, 2008, Diabetes & vascular disease research.

Tissue characterisation of atherosclerotic plaque in the left main: an in vivo intravascular ultrasound radiofrequency data analysis.

K. Kennedy, J. House, S. Marso, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Endovascular Ultrasound Renal Denervation to Treat Hypertension: The RADIANCE II Randomized Clinical Trial.

Raghava R. Gollapudi, A. Cremer, S. Padmanabhan, 2023, JAMA.

Application of the screening for Heart Attack Prevention and Education Task Force recommendations to an urban population: observations from the Dallas Heart Study.

A. Khera, C. Ayers, S. Grundy, 2008, Archives of internal medicine.

Drug-eluting stents and the use of percutaneous coronary intervention among patients with class I indications for coronary artery bypass surgery undergoing index revascularization: analysis from the NCDR (National Cardiovascular Data Registry).

J. Spertus, J. Rumsfeld, D. Cohen, 2009, JACC. Cardiovascular interventions.

Clinical and Economic Outcomes of Liberal Versus Selective Drug-Eluting Stent Use: Insights From Temporal Analysis of the Multicenter Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) Registry

M. Pencina, E. Mahoney, N. Kleiman, 2011, Circulation.

Evaluation of coronary artery calcium screening strategies focused on risk categories: the Dallas Heart Study.

A. Khera, S. Grundy, S. Murphy, 2009, American heart journal.

Endothelial progenitor cell mobilization after percutaneous coronary intervention.

Subhash Banerjee, E. Brilakis, L. Terada, 2006, Atherosclerosis.

Incomplete stent apposition: should we appose or oppose?

S. Marso, Jason B. Lindsey, 2010, JACC. Cardiovascular interventions.

M. Pencina, S. Goldberg, N. Kleiman, 2009, JACC. Cardiovascular interventions.

In-hospital outcomes and cost comparison of femoropopliteal reopening strategies.

E. Mahoney, K. Allen, J. House, 2011, Cardiovascular revascularization medicine : including molecular interventions.